MARKET

SILO

SILO

Silo Pharma Inc
NASDAQ
0.4388
-0.0127
-2.81%
After Hours: 0.4388 0 0.00% 16:43 12/05 EST
OPEN
0.4486
PREV CLOSE
0.4515
HIGH
0.4512
LOW
0.4388
VOLUME
60.99K
TURNOVER
--
52 WEEK HIGH
3.370
52 WEEK LOW
0.3601
MARKET CAP
5.84M
P/E (TTM)
-0.4738
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SILO last week (1124-1128)?
Weekly Report · 5d ago
Weekly Report: what happened at SILO last week (1117-1121)?
Weekly Report · 11/24 09:45
Silo Pharma CEO Eric Weisblum Acquires Common Shares
Reuters · 11/21 23:36
Silo Pharma CEO Eric Weisblum Reports Acquisition of Common Shares
Reuters · 11/20 21:01
Psychedelic: Clearmind reports results from first cohort in AUD trial
TipRanks · 11/20 17:05
Silo Pharma Partners with Allucent to Advance PTSD Drug Toward Clinical Trials
Reuters · 11/17 13:25
Silo Pharma partners with Allucent for planned FDA IND application for SPC-15
TipRanks · 11/17 13:11
SILO PHARMA INC - DATA FROM GLP-COMPLIANT TOXICOLOGY STUDY EXPECTED IN EARLY 2026
Reuters · 11/17 13:05
More
About SILO
Silo Pharma, Inc. is a diversified developmental-stage biopharmaceutical and cryptocurrency treasury company. The Company’s therapeutic focus is on addressing underserved conditions, including stress-induced psychiatric disorders, chronic pain, and central nervous system (CNS) diseases. The Company’s portfolio includes programs, such as for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer’s disease and multiple sclerosis. Its lead product candidate, SPC-15, is designed as a novel serotonin 4 (5-HT4) receptor agonist that utilizes biomarkers for treatment of stress-induced psychiatric disorders such as PTSD and anxiety disorders. SPC-14 targets glutamate receptor NDMAR and serotonin 5-HT4 to address cognitive and neuropsychiatric symptoms in Alzheimer’s disease. SPU-16 is a candidate targeting central nervous system (CNS) disorders, with an initial indication for multiple sclerosis.

Webull offers Silo Pharma Inc stock information, including NASDAQ: SILO real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SILO stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SILO stock methods without spending real money on the virtual paper trading platform.